文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

系统性风湿病危重患者的一年结局:多中心队列研究

One-Year Outcome of Critically Ill Patients With Systemic Rheumatic Disease: A Multicenter Cohort Study.
PubMed 文献 · Chest · 2020-04-11
一句话结论系统性风湿病危重患者住院死亡率30.5%、一年死亡率37.7%,年龄、既往糖皮质激素治疗及病情严重度与短期和长期死亡相关。

该多中心队列研究回顾了2006至2016年间收入ICU的525例系统性风湿病患者,评估住院及一年死亡率并识别死亡预测因素。入住原因以休克(40.8%)和急性呼吸衰竭(31.8%)最常见,主要诊断为感染(39%)和风湿病活动(35%)。住院死亡率为30.5%,一年死亡率为37.7%。与住院及一年死亡相关的预测因素包括年龄、既往糖皮质激素治疗、简化急性生理评分II≥50、需要有创机械通气或需要肾脏替代治疗;Knaus量表C或D级及既往传统改善病情抗风湿药治疗独立与ICU入科后一年死亡相关。

要点

  • 系统性风湿病危重患者住院死亡率为30.5%,一年死亡率为37.7%。
  • 入住ICU最常见原因为休克(40.8%)和急性呼吸衰竭(31.8%),主要诊断为感染(39%)和风湿病活动(35%)。
  • 与住院及一年死亡相关的因素包括年龄、既往糖皮质激素治疗、简化急性生理评分II≥50、需要有创机械通气或肾脏替代治疗。
  • Knaus量表C或D级及既往传统改善病情抗风湿药治疗独立与ICU入科后一年死亡相关。

适用人群与场景

  • 2006至2016年间收入ICU的系统性风湿病患者,共525例。

研究设计与关键结果

  • 多中心队列研究,纳入525例系统性风湿病ICU患者,入住原因以休克(40.8%)和急性呼吸衰竭(31.8%)最常见,主要诊断为感染(39%)和风湿病活动(35%)。
  • 住院死亡率为30.5%,一年死亡率为37.7%。
  • 与住院及一年死亡相关的预测因素分别为年龄、既往糖皮质激素治疗、简化急性生理评分II≥50、需要有创机械通气或需要肾脏替代治疗。
  • Knaus量表C或D级及既往传统改善病情抗风湿药治疗独立与ICU入科后一年死亡相关。

证据类型、等级与局限

  • 证据类型:多中心队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对系统性风湿病危重患者,年龄、既往糖皮质激素治疗、简化急性生理评分II≥50、需要有创机械通气或肾脏替代治疗可提示短期和长期死亡风险升高。
  • Knaus量表C或D级及既往传统改善病情抗风湿药治疗与ICU入科后一年死亡独立相关,作者认为既往健康状态和传统改善病情抗风湿药治疗也与一年死亡率相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Critically ill patients with systemic rheumatic disease (SRD) have benefited from better provision of rheumatic and critical care in recent years. Recent comprehensive data regarding in-hospital mortality rates and, most importantly, long-term outcomes are scarce.

RESEARCH QUESTION: The aim of this study was to assess short and long-term outcome of patients with SRD who were admitted to the ICU.

STUDY DESIGN AND METHODS: All records of patients with SRD who were admitted to ICU between 2006 and 2016 were reviewed. In-hospital and one-year mortality rates were assessed, and predictive factors of death were identified.

RESULTS: A total of 525 patients with SRD were included. Causes of admission were most frequently shock (40.8%) and acute respiratory failure (31.8%). Main diagnoses were infection (39%) and SRD flare-up (35%). In-hospital and one-year mortality rates were 30.5% and 37.7%, respectively. Predictive factors that were associated with in-hospital and one-year mortalities were, respectively, age, prior corticosteroid therapy, simplified acute physiology score II ≥50, need for invasive mechanical ventilation, or need for renal replacement therapy. Knaus scale C or D and prior conventional disease modifying antirheumatic drug therapy was associated independently with death one-year after ICU admission.

INTERPRETATION: Critically ill patients with SRD had a fair outcome after an ICU stay. Increased age, prior corticosteroid therapy, and severity of critical illness were associated significantly with short- and long-term mortality rates. The one-year mortality rate was also associated with prior health status and conventional disease modifying antirheumatic drug therapy.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Larcher R, Pineton de Chambrun M, Garnier F, et al. One-Year Outcome of Critically Ill Patients With Systemic Rheumatic Disease: A Multicenter Cohort Study. Chest. 2020. PMID: 32289313. doi:10.1016/j.chest.2020.03.050

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。